West Pharmaceutical Services (WST) reported $3.1B in revenue for fiscal 2025, +6.3% year on year. That ranks #1085 by revenue among 2853 SEC filers and #96 in Healthcare. Net income was $494M, a net margin of 16.1%. Revenue has grown 8.2% a year on average since 2016 ($1.5B then). The fiscal 2025 balance sheet shows $4.3B in total assets, $791M in cash and $203M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $3.1B | +6.3% | FY20252025-12-31 |
| Gross profitGrossProfit | $1.1B | +10.6% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $585M | +2.6% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $494M | +0.2% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $755M | +15.5% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $286M | −24.2% | FY20252025-12-31 |
| Total assetsAssets | $4.3B | +17.2% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $3.2B | +18.4% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $791M | +63.3% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $203M | +0.1% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $845M | $139M | Open → |
| Q2 20262026-06-30 | $872M | $154M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 36 of 161 companies compared | 16.1% | |
| Operating marginRank 39 of 160 companies compared | 19.0% | |
| R&D as share of revenueRank 89 of 102 companies compared | 2.4% | |
| Cash as share of revenueRank 35 of 160 companies compared | 25.7% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- West Pharmaceutical Services Inc
- Ticker
- WST
- Exchange
- NYSE
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0000105770
Filings
- 10-QJul 23, 2026Open filing →
- 10-QApr 23, 2026Open filing →
- 10-KFeb 17, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Brookdale Senior LivingBKD | $3.2B | −$263M |
| United TherapeuticsUTHR | $3.2B | $1.3B |
| Minimed GroupMMED | $3.1B | −$333M |
| West Pharmaceutical ServicesWST | $3.1B | $494M |
| Amneal PharmaceuticalsAMRX | $3.0B | $72.1M |
| Globus MedicalGMED | $2.9B | $538M |
| Bright Horizons Family SolutionsBFAM | $2.9B | $193M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=West Pharmaceutical Services — Key figures |url=https://companiesranked.com/en/company/west-pharmaceutical-services |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). West Pharmaceutical Services — Key figures. CompaniesRanked. https://companiesranked.com/en/company/west-pharmaceutical-servicesBibTeX
@misc{companiesranked-en-company-west-pharmaceutical-services-2026,
author = {{CompaniesRanked}},
title = {{West Pharmaceutical Services — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/west-pharmaceutical-services}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000105770-26-000010 · February 17, 2026
{{cite web |title=West Pharmaceutical Services — Key figures — 10-K (0000105770-26-000010) |url=https://www.sec.gov/Archives/edgar/data/105770/000010577026000010/wst-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.